IOVANCE BIOTHERAPEUTICS, INC. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Iovance Biotherapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Iovance Biotherapeutics, Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $4.5M, a 4.57% increase year-over-year.
  • Iovance Biotherapeutics, Inc. Operating Lease, Payments for the twelve months ending September 30, 2024 was $17.3M, a 3.62% increase year-over-year.
  • Iovance Biotherapeutics, Inc. annual Operating Lease, Payments for 2023 was $16.9M, a 18.7% increase from 2022.
  • Iovance Biotherapeutics, Inc. annual Operating Lease, Payments for 2022 was $14.2M, a 15.4% increase from 2021.
  • Iovance Biotherapeutics, Inc. annual Operating Lease, Payments for 2021 was $12.3M, a 47.1% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $16.9M +$2.66M +18.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $14.2M +$1.89M +15.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $12.3M +$3.94M +47.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 $8.37M -$250K -2.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-24
2019 $8.62M Jan 1, 2019 Dec 31, 2019 10-K 2021-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.